Transgenic mice with overexpression of NPY are more prone to doxorubicin mediated cardiomyopathy, whereas NPY knockout rats have improved cardiac function and reduced apoptosis following MI (Huang et al., 2019). Here, NPY is linked to myocardial infarction.